According to a report by UPI, on Friday, the Food and Drug Administration approved a 2.125 million-dollar treatment for spinal muscular atrophy, a genetic illness known as muscle-wasting disease that claims the lives of many babies before their 2nd birthday. UPI reports that the hefty price tag of the treatment makes it the most expensive drug in history. FDA acting Commissioner Ned Sharpless said, "Today's approval marks another milestone in the transformational power of gene and cell therapies to treat a wide range of diseases." The company reportedly said that it was working with at least 12 insurance companies to provide coverage for the drug.
This video was produced by YT Wochit News using
Food And Drug Administration,Gene Therapy,Spinal Muscular Atrophy,Zolgensma,Ned Sharpless,Vas Narasimhan,SMA,Novartis,Muscle,Genetics,Medicine,Drug Discovery,Neurogenetic Disorders,Motor Neuron Diseases,$2.125 Million,Two Years,UPI,Five Years,
0 Comments